As of 3:59pm ET
| -0.15 / -0.78%|
The 7 analysts offering 12-month price forecasts for Acorda Therapeutics Inc have a median target of 24.00, with a high estimate of 51.00 and a low estimate of 17.00. The median estimate represents a +25.98% increase from the last price of 19.05.
The current consensus among 8 polled investment analysts is to Hold stock in Acorda Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.